Menu
Recruiting NCT06145932

Repetitive Transcranial Magnetic Stimulation Therapy in Essential Tremor

No phase Interventional Essential Tremor

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: real rTMS, sham rTMS.
Who it may be relevant to
Registry conditions: Essential Tremor. Basic parameters: 18 years — 80 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
China
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

the Effects of Repetitive Transcranial Magnetic Stimulation and Mechanisms in Clinical Function of Essential Tremor

Overview

The purpose of this study is to evaluate the efficacy and electrophysiology of repetitive transcranial magnetic stimulation in the treatment of essential tremor.

Detailed description

This is a randomized controlled study.The purpose is to evaluate the efficacy of repetitive transcranial magnetic stimulation(rTMS) in the treatment of essential tremor,and explore the possible mechanism by detecting the changes of clinical scale and TMS-electroencephalogram(TMS-EEG), so as to seek an effective therapy for essential tremor.

Interventions

  • Device real rTMS
    treated with 1HZ rTMS 1800 pulses / day,for 10 days
  • Device sham rTMS
    treated with sham rTMS 1800 pulses / day,for 10 days

Primary outcome measures

  • The efficacy of the treatment on the essential tremor evaluated by Essential Tremor Rating Assessment Scale (TETRAS) score [Time frame: visit 1(baseline), visit 2(Day 10), visit 3(Day 30)]
  • Changes from baseline in tremor analysis [Time frame: visit 1(baseline), visit 2(Day 10), visit 3(Day 30)]
Secondary outcome measures (12)
  • Changes from baseline in TMS-EEG [Time frame: visit 1(baseline), visit 2(Day 10), visit 3(Day 30)]
  • Change in Non-Motor Symptoms Rating Scale (NMSS) score from baseline [Time frame: visit 1(baseline), visit 2(Day 10), visit 3(Day 30)]
  • Change in Mini-Mental State Examination (MMSE) score from baseline [Time frame: visit 1(baseline), visit 2(Day 10), visit 3(Day 30)]
  • Change in Montreal Cognitive Assessment (MOCA) score from baseline [Time frame: visit 1(baseline), visit 2(Day 10), visit 3(Day 30)]
  • Changes from baseline in Hamilton Anxiety Scale(HAMA) score [Time frame: visit 1(baseline), visit 2(Day 10), visit 3(Day 30)]
  • Changes from baseline in Hamilton Depression Scale-24(HAMD-24) score [Time frame: visit 1(baseline), visit 2(Day 10), visit 3(Day 30)]
  • Quality of Life Questionnaire (QUEST) score change from baseline [Time frame: visit 1(baseline), visit 2(Day 10), visit 3(Day 30)]
  • Change in Pittsburgh Sleep Quality Index (PSQI) score from baseline [Time frame: visit 1(baseline), visit 2(Day 10), visit 3(Day 30)]
  • Change in Fatigue Severity Scale (FSS) score from baseline [Time frame: visit 1(baseline), visit 2(Day 10), visit 3(Day 30)]
  • RBD Screening Questionnaire (RBDSQ) score [Time frame: visit 1(baseline)]
  • Test the sleep characteristics by polysomnography (PSG) [Time frame: visit 1(baseline)]
  • test the characteristics of vestibular evoked myogenic potential (VEMP) [Time frame: visit 1(baseline)]

Eligibility criteria

Inclusion criteria

  • Diagnosed as essential tremor conforming to the diagnostic criteria for essential tremor in the tremor group of the International Parkinson's and Movement Disorders Society (IPMDS).
  • Signed informed consent form.

Exclusion criteria

  • Complicated with brain organic diseases, epilepsy, other mental diseases, family history of dementia, metal devices implanted in the body and any contraindications to TMS;
  • History of craniocerebral surgery;
  • TMS cannot cooperate;
  • TMS-EEG examination artifacts are obvious, or cannot be analyzed due to other technical reasons.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Double blind
Primary purpose
Treatment

Study locations

China · 1 center
  • The Second Affiliated Hospital of Soochow University — Suzhou

Publications

  • Gironell A, Kulisevsky J, Lorenzo J, Barbanoj M, Pascual-Sedano B, Otermin P. Transcranial magnetic stimulation of the cerebellum in essential tremor: a controlled study. Arch Neurol. 2002 Mar;59(3):413-7. doi: 10.1001/archneur.59.3.413. PMID 11890845
  • Lv Y, Wang M, Yang J, Shi J, Xuan T, Zhang J, Du D, Cheng J, Li H. Cerebellar repetitive transcranial magnetic stimulation versus propranolol for essential tremor. Brain Behav. 2023 Mar;13(3):e2926. doi: 10.1002/brb3.2926. Epub 2023 Feb 17. PMID 36806734
  • Louis ED, Ferreira JJ. How common is the most common adult movement disorder? Update on the worldwide prevalence of essential tremor. Mov Disord. 2010 Apr 15;25(5):534-41. doi: 10.1002/mds.22838. PMID 20175185
  • Louis ED. The Roles of Age and Aging in Essential Tremor: An Epidemiological Perspective. Neuroepidemiology. 2019;52(1-2):111-118. doi: 10.1159/000492831. Epub 2019 Jan 9. PMID 30625472
  • Bal N, Sengul Y, Behmen MB, Powell A, Louis ED. Vestibular reflexes in essential tremor: abnormalities of ocular and cervical vestibular-evoked myogenic potentials are associated with the cerebellum and brainstem involvement. J Neural Transm (Vienna). 2023 Dec;130(12):1553-1559. doi: 10.1007/s00702-023-02652-3. Epub 2023 May 18. PMID 37199795
  • Berkiten G, Tutar B, Atar S, Kumral TL, Salturk Z, Akan O, Sari H, Onaran O, Biltekin Tuna O, Uyar Y. Assessment of the Clinical Use of Vestibular Evoked Myogenic Potentials and the Video Head Impulse Test in the Diagnosis of Early-Stage Parkinson's Disease. Ann Otol Rhinol Laryngol. 2023 Jan;132(1):41-49. doi: 10.1177/00034894211067838. Epub 2022 Feb 3. PMID 35114808
  • Bayramoglu B, Emre U, Erdal Y, Demirhan H, Yasak I, Yalin OO. Cervical vestibular-evoked myogenic potentials in patients with essential tremor. J Clin Neurosci. 2021 Sep;91:365-368. doi: 10.1016/j.jocn.2021.07.015. Epub 2021 Jul 30. PMID 34373053
  • Jimenez-Jimenez FJ, Alonso-Navarro H, Garcia-Martin E, Agundez JAG. Sleep disorders in essential tremor: systematic review and meta-analysis. Sleep. 2020 Sep 14;43(9):zsaa039. doi: 10.1093/sleep/zsaa039. PMID 32163585

Identifiers

NCT: NCT06145932 · JD-LK2023096-IR01

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗